Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Strategic Asset Allocation Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Strategic Asset Allocation Index of 21.7% as of September 2022. Strategic assets (PP&E of CN¥224.54 Million plus long-term investments of CN¥-) total CN¥224.54 Million, measured against net assets of CN¥1.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shenzhen Bioeasy Biotechnology Co. Ltd. balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shenzhen Bioeasy Biotechnology Co. Ltd. Strategic Asset Allocation Index (2017–2021)
This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of September 2022, the index stands at 21.7%, representing strategic assets of CN¥224.54 Million against net assets of CN¥1.03 Billion CNY. For live market cap and overall valuation, see Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) total market value.
Annual Strategic Asset Allocation Index for Shenzhen Bioeasy Biotechnology Co. Ltd. (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Bioeasy Biotechnology Co. Ltd. from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 300942 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 15.2% | CN¥143.44 Million | CN¥143.44 Million | CN¥- | CN¥946.58 Million | ▲ +7.0 pp |
| 2020 | 8.2% | CN¥44.89 Million | CN¥44.89 Million | CN¥- | CN¥548.98 Million | ▲ +2.6 pp |
| 2019 | 5.6% | CN¥29.41 Million | CN¥29.41 Million | CN¥- | CN¥528.32 Million | ▼ -1.5 pp |
| 2018 | 7.1% | CN¥15.73 Million | CN¥15.73 Million | CN¥- | CN¥222.62 Million | ▼ -4.2 pp |
| 2017 | 11.2% | CN¥12.87 Million | CN¥12.87 Million | CN¥- | CN¥114.60 Million | — |